| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 1.797 | 1.473 | 0 | - | 0 | 0 | 0 | 0 | 563 |
| Total Income - EUR | 0 | 1.797 | 1.473 | 6.447 | - | 0 | 0 | 0 | 0 | 563 |
| Total Expenses - EUR | 0 | 4.635 | 3.894 | 10.989 | - | 0 | 0 | 0 | 0 | 19.371 |
| Gross Profit/Loss - EUR | 0 | -2.838 | -2.420 | -4.542 | - | 0 | 0 | 0 | 0 | -18.808 |
| Net Profit/Loss - EUR | 0 | -2.883 | -2.435 | -4.626 | - | 0 | 0 | 0 | 0 | -18.808 |
| Employees | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Edith-Salino-Therapy Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 13.021 | 11.044 | 0 | - | 0 | 0 | 0 | 0 | 44.843 |
| Current Assets | 45 | 643 | -7 | 61 | - | 58 | 57 | 57 | 57 | 10.021 |
| Inventories | 0 | 155 | 0 | 0 | - | 0 | 0 | 0 | 0 | 8.154 |
| Receivables | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 92 |
| Cash | 45 | 488 | -7 | 61 | - | 58 | 57 | 57 | 57 | 1.775 |
| Shareholders Funds | 45 | -2.437 | -4.831 | -9.368 | - | -9.013 | -8.813 | -8.840 | -8.813 | -27.573 |
| Social Capital | 45 | 445 | 438 | 430 | - | 413 | 404 | 406 | 404 | 402 |
| Debts | 0 | 16.101 | 15.868 | 9.429 | - | 9.071 | 8.870 | 8.897 | 8.870 | 82.436 |
| Income in Advance | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9602 - 9602" | |||||||||
| CAEN Financial Year |
9602
|
|||||||||
Comments - Edith-Salino-Therapy Srl